Sarepta Therapeutics, Inc. · NASDAQ:SRPT
Vanguard Portfolio Management LLC reported a 8.05% stake in Sarepta Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 31, 2026
Vanguard Portfolio Management LLC reported a 8.05% stake in Sarepta Therapeutics, Inc., 8,499,421 shares, as a passive investor on Jun 30, 2026. Filed Jul 31, 2026 (Schedule 13G/A).
- Stake
- 8.05%
- Shares
- 8,499,421
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Portfolio Management | 8.05% | 8,499,421 |
Source
Related
- Sarepta Therapeutics, Inc.
- Vanguard Portfolio Management LLC
- Sarepta Therapeutics, Inc. shareholders
- Schedule 13G · Vanguard Portfolio Management LLC · Apr 29, 2026
- Form 4 · Wong Ryan Ho-Yan · Sep 8, 2026
- Form 4 · Estepan Ian Michael · Sep 8, 2026
- Form 4 · Rothfuss Cristin · Sep 8, 2026
- Form 4 · Rodino-Klapac Louise · Sep 8, 2026
- Schedule 13G/A · AQR Capital Management LLC · Aug 13, 2026